Electromed Historical Cash Flow
ELMD Stock | USD 16.39 0.67 4.26% |
Analysis of Electromed cash flow over time is an excellent tool to project Electromed future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 669.7 K or Other Non Cash Items of 531.1 K as it is a great indicator of Electromed ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Electromed latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Electromed is a good buy for the upcoming year.
Electromed |
About Electromed Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Electromed balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Electromed's non-liquid assets can be easily converted into cash.
Electromed Cash Flow Chart
Electromed Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Electromed Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At present, Electromed's Net Income is projected to increase significantly based on the last few years of reporting. The current year's Cash Flows Other Operating is expected to grow to about 334.5 K, whereas Change In Cash is projected to grow to (667.8 K). Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Electromed to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Electromed operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Electromed's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Electromed current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.At present, Electromed's Net Income is projected to increase significantly based on the last few years of reporting. The current year's Cash Flows Other Operating is expected to grow to about 334.5 K, whereas Change In Cash is projected to grow to (667.8 K).
Electromed cash flow statement Correlations
Click cells to compare fundamentals
Electromed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Electromed cash flow statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (449.3K) | 971K | (1.1M) | (1.0M) | (929.7K) | (883.2K) | |
Change In Cash | 2.7M | 1.4M | (3.7M) | (781K) | (702.9K) | (667.8K) | |
Stock Based Compensation | 901.9K | 1.0M | 976K | 708K | 814.2K | 491.5K | |
Free Cash Flow | 3.2M | 2.6M | (2.2M) | (401K) | (461.2K) | (438.1K) | |
Change In Working Capital | (1.5M) | (625K) | (4.1M) | (3.1M) | (2.8M) | (2.7M) | |
Begin Period Cash Flow | 7.8M | 10.5M | 11.9M | 8.2M | 9.4M | 4.9M | |
Other Cashflows From Financing Activities | (399.0) | (141K) | (77K) | (310K) | (279K) | (265.1K) | |
Depreciation | 738.2K | 610K | 628K | 613K | 705.0K | 669.7K | |
Other Non Cash Items | 18.0K | 2.6K | (2.7M) | 562K | 505.8K | 531.1K | |
Capital Expenditures | 977.2K | 448K | 1.5M | 1.7M | 2.0M | 1.0M | |
Total Cash From Operating Activities | 4.2M | 3.1M | (686K) | 1.3M | 1.5M | 1.4M | |
Change To Account Receivables | (180.6K) | (4.1M) | (4.0M) | (3.1M) | (2.8M) | (2.6M) | |
Net Income | 4.2M | 2.4M | 2.3M | 3.2M | 3.6M | 3.8M | |
Total Cash From Financing Activities | (548.0K) | (1.2M) | (1.5M) | (380K) | (342K) | (324.9K) | |
End Period Cash Flow | 10.5M | 11.9M | 8.2M | 7.4M | 8.5M | 5.3M | |
Change To Liabilities | (761.1K) | 1.3M | 1.9M | 705K | 810.8K | 467.1K | |
Sale Purchase Of Stock | (628K) | (1.1M) | (1.4M) | (153K) | (137.7K) | (144.6K) | |
Change Receivables | (180.6K) | (4.1M) | (4.0M) | (3.1M) | (2.8M) | (2.6M) | |
Total Cashflows From Investing Activities | (977.2K) | (448K) | (1.5M) | (1.7M) | (1.5M) | (1.5M) | |
Cash And Cash Equivalents Changes | 2.7M | 1.4M | (3.7M) | (781K) | (702.9K) | (667.8K) | |
Cash Flows Other Operating | (90.7K) | 923K | (947K) | 277K | 318.6K | 334.5K | |
Other Cashflows From Investing Activities | (133.0K) | (161K) | (100K) | (68K) | (61.2K) | (64.3K) | |
Change To Netincome | 778.6K | 730K | 487K | 665K | 764.8K | 561.5K | |
Change To Operating Activities | 78.2K | 151K | (1.1M) | 478K | 430.2K | 451.7K | |
Investments | (977.2K) | (448K) | (1.5M) | (1.7M) | (1.5M) | (1.6M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Electromed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Electromed's short interest history, or implied volatility extrapolated from Electromed options trading.
Pair Trading with Electromed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Electromed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Electromed will appreciate offsetting losses from the drop in the long position's value.Moving together with Electromed Stock
0.66 | FORA | Forian Inc Financial Report 10th of May 2024 | PairCorr |
Moving against Electromed Stock
0.79 | ICCM | Icecure Medical Financial Report 27th of May 2024 | PairCorr |
0.76 | GH | Guardant Health Upward Rally | PairCorr |
0.72 | SIBN | Si Bone Financial Report 6th of May 2024 | PairCorr |
0.68 | SRDX | SurModics Financial Report 24th of April 2024 | PairCorr |
0.62 | HCAT | Health Catalyst Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Electromed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Electromed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Electromed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Electromed to buy it.
The correlation of Electromed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Electromed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Electromed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Electromed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.